Posted by Irma Garcia on Jan 20th, 2025
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) was the target of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 11,200,000 shares, a drop of 8.1%...
More of this article »